Researchers say the discovery is unexpected because prions are usually discussed in the context of misfolding, aggregation, and brain disease—not immunity or antibiotic discovery.

AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion, in a deal designed to bolster the buyer’s pipeline with an atopic dermatitis (AD) candidate set to advance to Phase III trials ...

The prevalence of autism spectrum disorder (ASD) is roughly one in 36 people, with a male-to-female ratio of 4:1. The disorder is known to be influenced by multiple factors, both genetic (gene ...

A second positive Phase III data readout in two months is a major reason why Intellia Therapeutics shares have soared more than 76% over the past six months—including a 29% surge this past week that ...

The team created highly precise tissue-specific clocks, capable of predicting age within about one year of an individual’s chronological age.

Biotechnology, healthcare, and biomedical technologies clearly are at the top of senior government officials’ priority list.

In separate lectures presented during the award ceremony, both scientists spoke on the many benefits of and future directions for CAR T cells.

TALOS is designed to replace traditional variable pathlength UV workflows with a simpler fixed-path near-infrared measurement ...

Researchers say technology has the potential to revolutionize the field of pediatric laryngotracheal reconstruction.

A new continuous bioprocessing platform for advanced therapy medicinal products (ATMPs) could help manufacturers increase yields and improve productivity, allowing them to treat larger groups of ...

New framework helps biomanufacturers’ interventions, eyeing quality, cost, and stability for two-step chromatography decisions.

NorthX Biologics and enGenes Biotech team to develop an integrated, bacterial-based protein production platform.